comparemela.com
  1. Home
  2. Live Updates
  3. Youxin Chen - Breaking News

Latest Breaking News On - Youxin chen - Page 1 : comparemela.com

Innovent Announces First Participant Dosed in Phase 1 Clinical Study of IBI333 (VEGF-A/VEGF-C Bispecific Fusion Protein) in Patients with Neovascular Age-related Macular Degeneration

/PRNewswire/ Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

Hong kongInnovent biologicsYouxin chenAdimab incyteEli lillyClinical development of innoventMd anderson cancer centerUnion medical college hospitalLancet glob healthInnovent biologics incPeking union medical college hospitalPrincipal investigatorLei qianVice presidentClinical developmentMain board

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.